Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriatic arthritis clinical trial 2.

van der Heijde, D; Kavanaugh, A; Gladman, D D; Antoni, C; Krueger, G G; Guzzo, C; Zhou, B; Dooley, L T; de Vlam, K; Geusens, P; Birbara, C; Halter, D; Beutler, A

van der Heijde, D; Kavanaugh, A; Gladman, D D; Antoni, C; Krueger, G G; Guzzo, C; Zhou, B; Dooley, L T; de Vlam, K; Geusens, P; Birbara, C; Halter, D; Beutler, A.

Affiliation

van der Heijde D; Leiden University Medical Center, Leiden, The Netherlands. d.vanderheijde@kpnplanet.nl

Arthritis Rheum ; 56(8): 2698-707, 2007 Aug.

Article in En | MEDLINE | ID: mdl-17665424

Subject(s)

Antibodies, Monoclonal/therapeutic use; Antirheumatic Agents/therapeutic use; Arthritis, Psoriatic/diagnostic imaging; Arthritis, Psoriatic/drug therapy; Arthritis, Psoriatic/physiopathology; Disease Progression; Double-Blind Method; Female; Health Status; Humans; Infliximab; Joints/pathology; Male; Middle Aged; Radiography; Severity of Illness Index; Surveys and Questionnaires

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Psoriatic / Antirheumatic Agents / Antibodies, Monoclonal Type of study: Clinical_trials / Diagnostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Arthritis Rheum Year: 2007 Type: Article Affiliation country: Netherlands

Search on Google

XML

PubMed Links